Replies to post #570905 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

6-12 months is the norm

For a personalized dendritic cell vaccine?! complete bullshit.

Another bear narrative based on nothing more than fabrications that disparages management.

These bear narratives are trying really really hard to convince shareholders that the management that just delivered landmark trial results and are about to submit multiple RA applications is the worse management in the world. Yet, NWBO's management delivered a successful trial where 400+ other teams failed. I find these repeated bear narratives based on fabrications and baseless speculation to be comical.

Have a good one Ex! by.

[aesop1]

I would say 6 months is the normal timeframe for nda/bla submission and 12 months would be considered slow. And yes that timeline applies even if it is personalized immunotherapy. You can go check the historical timeline on Dendreon wikipedia. 1 year from top line data to US FDA approval. (top line in April 2009, FDA BLA submission in November 2009, and FDA Approval in April 2010). The sad part is the investors are used to the company missing timelines and now having no timelines. This is why there is all this speculation on where things stand.